Saturday, July 5, 2008
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business
Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Sat, 17 May 2008 00:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/107820.php
Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human TrialsPulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB) has announced details of the methodology and purpose of its Phase I Human Trials with its PulmoBind Molecular Imaging technology for the diagnosis of Pulmonary Embolism and Pulmonary Hypertension. The work will be carried out by the Pulmo BioTech subsidiary, PulmoScience Inc.
Click here for full Story
http://www.medicalnewstoday.com/articles/107820.php
Bookmark this news story online:
Add Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to BlinkListAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to DeliciousAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to DiggAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to FarkAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to FurlAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to BlogarithmAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to MeneameAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to My Yahoo!Add Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to ReddItAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to ShadowsAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to SimpyAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to SpurlAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Sync2ItAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to MagnoliaAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to NewsVineAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Ask Jeeves
Add Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Raw SugarAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to DiigoAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to NetVouzAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Stumble UponAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to SegnaloAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Google BookmarksAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Microsoft LiveAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to BlogMarksAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to WinkAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to TechnoratiAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Feed Me LinksAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to LinkaGoGoAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to BlueDotAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Mister WongAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to TailRankAdd Pulmo BioTech Announces Details Of The Methodology For Its Phase I Human Trials to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet ATL/TV1102, A Novel Drug For The Treatment Of Relapsing Remitting Multiple Sclerosis, Demonstrated Significant Reduction In Disease Activity
bullet No Evidence Of Widespread Failure Of Maternity Care - New Zealand Medical Association
bullet New Research With GPs Suggests Sick Notes Are A Complex Issue, UK
bullet Florida Health Insurance Analyst Says McCain's Group Health Ideas Bad For Employees
bullet Hepatitis C Vaccine Delivered By Inovio Biomedical's Electroporation System Shows Increased T-Cell Responses And Reduced Viral Loads, Study
bullet New Impact Factor Of European Urology Underlines Journal's Outstanding Position
bullet European Association Of Urology Research Foundation Has New Chairman
bullet 3rd ESU Masterclass Presents Insightful Updates On Urological Oncology
bullet NMC Responds To EU Directive On Cross Border Healthcare, UK
bullet Double Jobbing Nurse Cautioned For Dishonesty, UK
bullet CPME Welcomes The Adoption Of A Proposal For A Directive On Patients' Rights In Cross-Border Care, Europe
bullet HDMA Co-Sponsors Import Safety Summit As Part Of An Ongoing Commitment To Patient Safety And Supply Chain Security
bullet Industrial Estates Warned Of Health And Safety Spot Inspections In Herts And Beds, UK
bullet Labor Board Sets Trial On Charges Fremont-Rideout Violated Federal Law, California Nurses Association
bullet Death Of Psychiatric Patient At New York Hospital Underscores Mental Health Care Crisis
bullet Health Unions Win 10 Per Cent Increase On Mileage Allowances For UK Nurses
bullet New Book Charts 100 Year History Of The NFU And Agriculture
bullet Medicare Adds Third Recognized Source To Help Determine Coverage For Anti-Cancer Chemotherapy Drugs
bullet CMS Proposes Quality Improvements And Other Changes For Hospital Outpatient And Ambulatory Surgical Center Services For 2009
bullet Health Canada Renews Funding To The Canadian Patient Safety Institute
bullet BDA Response To NHS Next Stage Review, UK
bullet Terrence Higgins Trust Offers One Hour HIV Testing In Hastings, UK
bullet BIO Applauds U.S. Adoption For GE Corn, Cotton, Soybeans
bullet NDC Update: ASHP Continues To Pursue Options For Relief From Reporting Requirement
bullet ASHP Offers Expertise To New NABP Medication Safety Task Forces
 
© 2007 Verge Systems